Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

A rare genetic condition can mimic symptoms of other diseases, making diagnosis challenging.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

Early diagnosis and treatment by vets are crucial for managing rare but severe feline skin disorders.

Type 1 diabetes patients often have other autoimmune diseases, which complicate their care.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

The child was diagnosed with a skin condition involving inflamed hair follicles.

Ocrelizumab may cause pancreatitis in some patients.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

A woman with skin eruptions and hair loss improved significantly with ointment treatment.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

TNF-a may not be as involved in certain types of hair loss as previously thought.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.